Industry News

New Vaccines Expected to Bolster Adult Immunization Sales

Published in Hepatitis Weekly, April 3rd, 2000

The U.S. market for vaccines totaled $2.0 billion in 1999, growing 8.6% annually from 1994, according to a recent study published by Kalorama Information, a publisher of market research.

Sales are expected to increase 6.9% annually from 1999-2004, reaching 2.8 billion. Sales of pediatric vaccines were the largest industry segment, accounting for 64.3% of overall revenues in 1999, and reaching $1.3 billion.

Adult vaccines grew 9.9% annually between 1994-1999 to $711.2 million, an increase of $266 million over the five-year period. Overall domination of the market came from Merck & Company, SmithKline Beecham, Pasteur Merieux Connaught, and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-04-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry